{
	"kj8tvpzdText": "Ef<span class=\"_ _b\"></span>fec<span class=\"_ _b\"></span>t<span class=\"_ _1\"></span>s of<span class=\"_ _1\"></span> ps<span class=\"_ _1\"></span>y<span class=\"_ _0\"></span>cho<span class=\"_ _1\"></span>tr<span class=\"_ _1\"></span>opic agent<span class=\"_ _1\"></span>s<span class=\"_ _1\"></span> on cognit<span class=\"_ _1\"></span>ive <br>func<span class=\"_ _b\"></span>tion<span class=\"_ _1\"></span> in MDD<span class=\"fs2 ls0 v1\">1</span>",
	"kj8tvpzeText": "Hierarchy for antidepressant<span class=\"_ _1\"></span>s/<span class=\"_ _0\"></span>psychotropic<span class=\"_ _1\"></span>s independently improving measures of<span class=\"_ _1\"></span> <br><span class=\"ls6 ws18\">cognition in young adults wit<span class=\"_ _1\"></span>h MDD (independence suggested<span class=\"_ _1\"></span> by either path analy<span class=\"_ _1\"></span>sis or <br><span class=\"ls7 ws19\">s<span class=\"_ _1\"></span>ubgroup analysi<span class=\"_ _1\"></span>s<span class=\"_ _2\"></span>)</span></span>",
	"kj8tvpzfText": "Level 1: <span class=\"ff2\">Replicated placebo-contr<span class=\"_ _0\"></span>olled trial evidence with demonstration of independent effect<br><span class=\"ff1\">Level 2: </span>Single placebo-controlled trial evidence with demonstra<span class=\"_ _0\"></span>tion of<span class=\"_ _1\"></span> independent effect<br><span class=\"ff1\">L<span class=\"_ _0\"></span>evel 3: <span class=\"ff2\">Uncontrolled evidence (eg lacking placebo, case-series) with lack of demonstration of independent effect<br>Independent effect indica<span class=\"_ _0\"></span>ted by a priori specification, cognition as primary; path-analysis; subgroup analysis in non-r<span class=\"_ _0\"></span>esponders and non-remitters<br>SSRI, selective ser<span class=\"_ _0\"></span>otonin reuptake inhibitor; SNRI, selective nor<span class=\"_ _0\"></span>adrenaline reuptake inhibitor</span></span></span>",
	"kj8tvpzgText": "BrintellixÂ®<span class=\"_\"> </span>1",
	"kj8tvpzhText": "1",
	"kj8tvpziText": "-",
	"kj8tvpzjText": "3",
	"kj8tvpzkText": "3",
	"kj8tvpzlText": "2",
	"kj8tvpzmText": "1",
	"kj8tvpznText": "-",
	"kj8tvpzoText": "-",
	"kj8tvpzpText": "3",
	"kj8tvpzqText": "3",
	"kj8tvpzrText": "2",
	"kj8tvpzsText": "1",
	"kj8tvpztText": "-",
	"kj8tvpzuText": "2",
	"kj8tvpzvText": "3",
	"kj8tvpzwText": "3",
	"kj8tvpzxText": "2",
	"kj8tvpzyText": "1",
	"kj8tvpzzText": "-",
	"kj8tvq00Text": "-",
	"kj8tvq01Text": "3",
	"kj8tvq02Text": "3",
	"kj8tvq03Text": "2",
	"kj8tvq04Text": "Duloxetine",
	"kj8tvq05Text": "Lis-<span class=\"_ _1\"></span>dexamphetamine",
	"kj8tvq06Text": "Modafinil",
	"kj8tvq07Text": "Er<span class=\"_ _1\"></span>y<span class=\"_ _1\"></span>thropoietin",
	"kj8tvq08Text": "Other<span class=\"_ _1\"></span> (<span class=\"_ _2\"></span>eg SSRI<span class=\"_ _1\"></span>s, SNRIs,<span class=\"_\"> </span> b<span class=\"_ _1\"></span>upropion<span class=\"_ _2\"></span>)",
	"kj8tvq09Text": "Learning and ",
	"kj8tvq0aText": "Memor<span class=\"_ _1\"></span>y",
	"kj8tvq0bText": "Executive ",
	"kj8tvq0cText": "func<span class=\"_ _1\"></span>tion",
	"kj8tvq0dText": "At<span class=\"_ _1\"></span>tentio<span class=\"_ _1\"></span>n/",
	"kj8tvq0eText": "concentrat<span class=\"_ _1\"></span>ion",
	"kj8tvq0fText": "Processing ",
	"kj8tvq0gText": "speed",
	"kj8tvq0iText": "PDQ<span class=\"_\"> </span><span class=\"ff1 fc3 wsa\">Level of Evidence<span class=\"_ _c\"></span><span class=\"ff3 fc0 ws15\">DSST<span class=\"_ _d\"> </span>Comparison</span></span>",
	"Brintellix_30fcc331a4": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 15px;\"><b>1.</b> McIntyre RS et al. CNS Drugs 2015;29:577-589.\n</font>\n</span>",
	"Brintellix_30d6b21191": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); \">\n<font style=\"font-size: 25px;\">References</font>\n</span>",
	"Brintellix_30712fd7a9": "Text",
	"Brintellix_305dc9997d": "Text",
	"Brintellix_30aa354401": "Text",
	"Brintellix_3017ed8e38": "Text",
	"Brintellix_304a22aa1c": "Text",
	"Brintellix_3084e8dd2f": "Text",
	"Brintellix_304904c3c3": "Text",
	"Brintellix_30ccb967fb": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;color: #4d7f86;\"><span style=\"color: #fff;\">Cognitive Symptoms</span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Functionality&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Motivation &amp; Energy&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Goal Attainment</div>"
}
